摘要
慢性淋巴细胞白血病(CLL)是一种淋巴细胞克隆性增殖的肿瘤性疾病,近年来关于CLL的基础和临床研究已经取得多项重大进展。2020年第62届美国血液学会(ASH)年会就该疾病基础研究的最新进展进行了详细报道,使人们对CLL的发生、发展过程有了更加深入的了解,并对临床治疗起到了一定的指导作用。
Chronic lymphocytic leukemia(CLL)is an oncologic disease with clonal proliferation of lymphocytes.In recent years,great advances have been made in the basic and clinical research of CLL.The 62nd American Society of Hematology Annual Meeting in 2020 presented a detailed report on the latest advance in basic research on these diseases,providing a deeper understanding of how CLL occurs and develops,and playing a guidance role in the clinical treatment.
作者
左小玲
李建勇
范磊
Zuo Xiaoling;Li Jianyong;Fan Lei(Department of Hematology,Jiangsu Province Hospital,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China)
出处
《白血病.淋巴瘤》
CAS
2021年第3期141-143,共3页
Journal of Leukemia & Lymphoma
基金
希思科临床肿瘤学研究基金(Y‑Roche2019/2‑0090)。